Lyotropic Delivery Systems (LDS) is a biotechnology company focusing on the development of drug delivery based on liquid nano-sized delivery systems.

LDS's proprietary technology enables solubilizing large loads of poorly absorbed macromolecules, enhancing their transport across the gastrointestinal wall to the bloodstream without modifying the therapeutic compounds.This approach is based on the formation of modified soft and fluid gel mesophases with characteristics between a liquid and a crystal.

The mesophases are composed of water nano-channels packed in unique symmetries, which are thermodynamically stable at various temperatures, resulting in long shelf life.LDS's portfolio comprises a range of projects including oral, ocular, and transdermal applications.The company's technology creates new uses for generic or innovative drugs, by using safe-to-use components, which are all categorized as generally recognized as safe and/or are listed within the FDA Inactive Ingredient Guide database.